ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2025
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2025 |
| [05-January-2026] |
Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year. GOTHENBURG, Sweden, Jan. 5, 2026 /PRNewswire/ -- The revenue in December for Zinzino's sales markets increased by 35 % and amounted to SEK 334.4 (246.9) million. Faun Pharma's external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33 % to SEK 337.3 (252.7) million compared with the previous year. Revenue in Zinzino's sales markets increased by 50 % in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.3) million. Total revenues in the Group increased by 46 % in the fourth quarter and amounted to SEK 1,042.4 (713.5) million. Accumulated revenue for January - December 2025 increased by 51% to SEK 3,344.5 (2,207.8) million. Revenues were distributed as follows:
Countries in regions:
For more information: Pictures for publication free of charge: marketing@zinzino.com Certified Adviser: DNB Carnegie Investment Bank AB (publ.) This information was brought to you by Cision http://news.cision.com https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-2025,c4288720 The following files are available for download:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Codes: ISIN:SE0002480442,Stockholm:ZZ-B |











